title: HAART and the liver: friend or foe?
abstract: The overall effect of HAART on the liver is the result of the balance between hepatotoxicity and the consequences of immunoreconstitution on the evolution of HIV-associated liver diseases, particularly viral hepatitis. HAART may lead to the emergence of acute toxic hepatitis, steatosis, steatohepatitis, liver fibrosis, and noncirrhotic portal hypertension. On the other hand, HAART use has been associated with slower fibrosis progression in HIV/HCV-coinfected patients in most studies dealing with this issue. As well, an improvement of the clinical outcome of liver disease has been reported in patients taking HAART. For these reasons, the short- and mid-term effects of HAART on the liver are mostly beneficial.
authors.affiliation: Unit of Infectious Diseases, Hospital Universitario de Valme, Sevilla, Spain. japineda@telefonica.net
authors.forename: J A
authors.initials: JA
authors.lastname: Pineda
authors.forename: J
authors.initials: J
authors.lastname: Macías
authors.forename: J A
authors.initials: JA
authors.lastname: Mira
authors.forename: N
authors.initials: N
authors.lastname: Merchante
authors.forename: J
authors.initials: J
authors.lastname: del Valle
authors.forename: K I
authors.initials: KI
authors.lastname: Neukam
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000209:etiology; D011379:Prognosis
references.citation: AIDS. 2006 Jan 2;20(1):49-57
references.pmid: 16327319
references.citation: AIDS Res Hum Retroviruses. 2009 Apr;25(4):383-5
references.pmid: 19320566
references.citation: J Infect Dis. 2005 Nov 1;192(9):1566-76
references.pmid: 16206071
references.citation: Med Clin (Barc). 2009 Feb 21;132(6):208-13
references.pmid: 19237003
references.citation: Clin Infect Dis. 2008 Jan 1;46(1):137-43
references.pmid: 18171229
references.citation: Am J Gastroenterol. 2007 Nov;102(11):2536-40
references.pmid: 17640321
references.citation: J Acquir Immune Defic Syndr. 2006 Jun;42(2):177-82
references.pmid: 16688096
references.citation: Clin Infect Dis. 2001 Aug 15;33(4):562-9
references.pmid: 11462196
references.citation: J Antimicrob Chemother. 2007 Jan;59(1):87-91
references.pmid: 17095528
references.citation: Hepatology. 1999 Oct;30(4):1054-8
references.pmid: 10498659
references.citation: AIDS. 2007 Jan 11;21(2):187-92
references.pmid: 17197809
references.citation: Enferm Infecc Microbiol Clin. 2008 Oct;26(8):500-1
references.pmid: 19094863
references.citation: AIDS. 2008 Oct 1;22(15):1979-91
references.pmid: 18784461
references.citation: Lancet. 2003 Nov 22;362(9397):1708-13
references.pmid: 14643119
references.citation: Gut. 2009 Dec;58(12):1654-60
references.pmid: 19625279
references.citation: AIDS. 2004 Mar 26;18(5):767-74
references.pmid: 15075511
references.citation: J Hepatol. 2006 Jan;44(1):47-55
references.pmid: 16182404
references.citation: AIDS. 2008 Jan 11;22(2):203-10
references.pmid: 18097222
references.citation: AIDS. 2005 Sep 2;19(13):1375-83
references.pmid: 16103768
references.citation: Hepatology. 2007 Sep;46(3):622-30
references.pmid: 17659577
references.citation: Curr Opin Lipidol. 2001 Jun;12(3):313-9
references.pmid: 11353335
references.citation: Antivir Ther. 2008;13(1):103-7
references.pmid: 18389904
references.citation: AIDS. 2007 Oct 18;21(16):2209-16
references.pmid: 18090048
references.citation: Clin Infect Dis. 2006 Jan 15;42(2):262-70
references.pmid: 16355339
references.citation: Gastroenterology. 2008 Mar;134(3):803-11
references.pmid: 18325393
references.citation: AIDS. 2005 Mar 24;19(6):585-92
references.pmid: 15802977
references.citation: J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):168-73
references.pmid: 17527092
references.citation: AIDS. 2004 Oct 21;18(15):2039-45
references.pmid: 15577625
references.citation: World J Gastroenterol. 2009 Feb 28;15(8):996-1003
references.pmid: 19248201
references.citation: PLoS One. 2009;4(2):e4517
references.pmid: 19223976
references.citation: Clin Infect Dis. 2006 Aug 1;43(3):365-72
references.pmid: 16804853
references.citation: Clin Infect Dis. 2004 Jan 1;38(1):128-33
references.pmid: 14679458